Common Contracts
3 similar Transition Services Agreement contracts by Haleon PLC
TRANSITION SERVICES AGREEMENT dated 1 June 2022 by GLAXOSMITHKLINE SERVICES UNLIMITED Provider and GLAXOSMITHKLINE CONSUMER HEALTHCARE (OVERSEAS) LIMITED Recipient and GLAXOSMITHKLINE LLC U.S. Provider and GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS...Transition Services Agreement • June 1st, 2022 • Haleon PLC • Perfumes, cosmetics & other toilet preparations
This TRANSITION SERVICES AGREEMENT (this “Agreement”) is made and entered into as of the 1st day of June, 2022 among (i) GlaxoSmithKline Services Unlimited, a company incorporated under the laws of England (“Provider”) and, for purposes of Section 3.3(b), Section 9.3(a)(v), and Article X only, GlaxoSmithKline LLC, a Delaware limited liability company (“U.S. Provider”), on the one hand, and (ii) GlaxoSmithKline Consumer Healthcare (Overseas) Limited, a company incorporated under the laws of England and Wales (“Recipient”) and, for purposes of Section 3.3(b), Section 9.3(a)(v), and Article X only, GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, a Delaware limited liability company (“U.S. Recipient”), on the other hand (each of Provider and Recipient, a “Party” and together, the “Parties,” except with respect to Section 3.3(b), Section 9.3(a)(v), and Article X, wherein Provider and U.S. Provider, on the one hand, and Recipient and U.S. Recipient, on the other hand, each, individual
TRANSITION SERVICES AGREEMENT dated by GLAXOSMITHKLINE SERVICES UNLIMITED Provider and GLAXOSMITHKLINE CONSUMER HEALTHCARE (OVERSEAS) LIMITED Recipient and GLAXOSMITHKLINE LLC U.S. Provider and GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC...Transition Services Agreement • May 24th, 2022 • Haleon PLC • Perfumes, cosmetics & other toilet preparations
This TRANSITION SERVICES AGREEMENT (this “Agreement”) is made and entered into as of the day of , 202 among (i) GlaxoSmithKline Services Unlimited, a company incorporated under the laws of England (“Provider”) and, for purposes of Section 3.3(b), Section 9.3(a)(v), and Article X only, GlaxoSmithKline LLC, a Delaware limited liability company (“U.S. Provider”)], on the one hand, and (ii) GlaxoSmithKline Consumer Healthcare (Overseas) Limited, a company incorporated under the laws of England and Wales (“Recipient”) and, for purposes of Section 3.3(b), Section 9.3(a)(v), and Article X only, GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, a Delaware limited liability company (“U.S. Recipient”), on the other hand (each of Provider and Recipient, a “Party” and together, the “Parties,” except with respect to Section 3.3(b), Section 9.3(a)(v), and Article X, wherein Provider and U.S. Provider, on the one hand, and Recipient and U.S. Recipient, on the other hand, each, individually and c
TRANSITION SERVICE AGREEMENT dated by GLAXOSMITHKLINE SERVICES UNLIMITED Provider and GLAXOSMITHKLINE CONSUMER HEALTHCARE (OVERSEAS) LIMITED Recipient and GLAXOSMITHKLINE LLC U.S. Provider and GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC U.S....Transition Services Agreement • May 10th, 2022 • Haleon PLC • Perfumes, cosmetics & other toilet preparations
This TRANSITION SERVICES AGREEMENT (this “Agreement”) is made and entered into as of the day of , 202 among (i) GlaxoSmithKline Services Unlimited, a company incorporated under the laws of England (“Provider”) and, for purposes of Section 3.3(b), Section 9.3(a)(v), and Article X only, GlaxoSmithKline LLC, a Delaware limited liability company (“U.S. Provider”)], on the one hand, and (ii) GlaxoSmithKline Consumer Healthcare (Overseas) Limited, a company incorporated under the laws of England and Wales (“Recipient”) and, for purposes of Section 3.3(b), Section 9.3(a)(v), and Article X only, GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, a Delaware limited liability company (“U.S. Recipient”), on the other hand (each of Provider and Recipient, a “Party” and together, the “Parties,” except with respect to Section 3.3(b), Section 9.3(a)(v), and Article X, wherein Provider and U.S. Provider, on the one hand, and Recipient and U.S. Recipient, on the other hand, each, individually and c
